Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Annelies Nijdam"'
Autor:
Eline M J Lammers, Josée M Zijlstra, Valesca P Retèl, Berthe M P Aleman, Flora E van Leeuwen, Annelies Nijdam
Publikováno v:
JMIR Research Protocols, Vol 13, p e55601 (2024)
BackgroundHodgkin lymphoma (HL) occurs at young ages, with the highest incidence between 20 and 40 years. While cure rates have improved to 80%-90% over the past decades, survivors of HL are at substantial risk of late treatment–related complicatio
Externí odkaz:
https://doaj.org/article/96733ba3b3c14f89b8567a50ad39b2a8
Autor:
Eline M.J. Lammers, Annelies Nijdam, Josée. M. Zijlstra, Cécile P.M. Janus, Roel J. De Weijer, Flora E. Van Leeuwen, Berthe M. P. Aleman, On Behalf Of The Beter Consortium
Publikováno v:
HemaSphere, Vol 6, Pp 32-33 (2022)
Externí odkaz:
https://doaj.org/article/9d050c1586c444ac9a7c7aeaa8a2dc4d
Autor:
Adinda Mieras, Annelies Nijdam, Berthe M. P. Aleman, Laurien Daniels, Eva De Jongh, Cécile P.M. Janus, Stijn Krol, Bastiaan D.P. Ta, Francisca Ong, Dick Johan Van Spronsen, Ward Posthuma, Wouter J. Plattel, Rimke Oostvogels, Karijn Verschueren, Josée. M. Zijlstra, Flora E. Van Leeuwen
Publikováno v:
HemaSphere, Vol 6, Pp 36-37 (2022)
Externí odkaz:
https://doaj.org/article/a6bd26d1d1a14604b3c466325b58bc48
Autor:
Annelies Nijdam, Eline M.J. Lammers, Berthe M. P. Aleman, Josée. M. Zijlstra, Flora E. Van Leeuwen, On Behalf Of The Beter Consortium
Publikováno v:
HemaSphere, Vol 6, Pp 32-32 (2022)
Externí odkaz:
https://doaj.org/article/e68cddc8957b4a2f86c4e63f1c949217
Autor:
Annelies Nijdam, Carmen Altisent, Manuel D. Carcao, Ana R. Cid, Ségolène Claeyssens-Donadel, Karin Kurnik, Rolf Ljung, Beatrice Nolan, Pia Petrini, Helen Platokouki, Anne Rafowicz, Angela E. Thomas, Kathelijn Fischer
Publikováno v:
Haematologica, Vol 100, Iss 3 (2015)
Externí odkaz:
https://doaj.org/article/0fc9dbf7563d408181989c0343f7738b
Autor:
Mars B. van 't Veer, Flora E. van Leeuwen, Rinske S. Boersma, John M. M. Raemaekers, Annelies Nijdam, Bastiaan D. Ta, Laurien A. Daniels, Roel J. de Weijer, Eduardus F. M. Posthuma, Maaike J. van den Heuvel, Floriske G. Stedema, Nicky Dekker, Annelies Manenschijn, Michel F. H. Dielwart, Yavuz M. Bilgin, Berthe M.P. Aleman, Josée M. Zijlstra, Cecile P.M. Janus, Richard W.M. van der Maazen
Publikováno v:
Nijdam, A, Dekker, N, Aleman, B M P, van ’t Veer, M B, Daniels, L A, van der Maazen, R W, Janus, C P M, de Weijer, R J, Zijlstra, J M, Stedema, F G, Ta, B D, Posthuma, E F M, Manenschijn, A, Dielwart, M F H, Bilgin, Y M, van den Heuvel, M J, Boersma, R S, van Leeuwen, F E, Raemaekers, J M M & the BETER consortium 2019, ' Setting up a national infrastructure for survivorship care after treatment for Hodgkin lymphoma ', British Journal of Haematology, vol. 186, no. 4, pp. e103-e108 . https://doi.org/10.1111/bjh.15936
British Journal of Haematology, 186(4), E103-E108. Wiley-Blackwell Publishing Ltd
British Journal of Haematology, 186(4), E103-E108. Wiley
British Journal of Haematology, 186, e103-e108
British Journal of Haematology, 186, 4, pp. e103-e108
British Journal of Haematology, 186(4), e103-e108. Wiley-Blackwell
British Journal of Haematology, 186(4), E103-E108. Wiley-Blackwell Publishing Ltd
British Journal of Haematology, 186(4), E103-E108. Wiley
British Journal of Haematology, 186, e103-e108
British Journal of Haematology, 186, 4, pp. e103-e108
British Journal of Haematology, 186(4), e103-e108. Wiley-Blackwell
Contains fulltext : 208562.pdf (Publisher’s version ) (Closed access)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0ad1fa7595da6f26c5d4b9e2f7c34ad
https://doi.org/10.1111/bjh.15936
https://doi.org/10.1111/bjh.15936
Autor:
M. B. Van't Veer, F.E. van Leeuwen, C.P.M. Janus, B.M.P. Aleman, J.M. Zijlstra, Pieternella J. Lugtenburg, Annelies Nijdam, R.J. de Weijer, Eefke Petersen, R.W.M. van der Maazen, Judith M. Roesink, J M Raemaekers
Publikováno v:
Hematological Oncology. 35:309-309
Autor:
Flora E. van Leeuwen, Pieternella J. Lugtenburg, Cecile P.M. Janus, Berthe M.P. Aleman, Judith M. Roesink, Eefke J. Clevers-Petersen, Mars B. van ’t Veer, Annelies Nijdam, John M. M. Raemaekers, Roel J. de Weijer
Publikováno v:
Journal of Clinical Oncology. 35:71-71
71 Background: Survivors of Hodgkin lymphoma (HL) are at risk for late adverse effects of treatment. The Dutch BETER consortium, consisting of healthcare providers, researchers and patient representatives, has set up survivorship care clinics where H